Free Trial

ESSA Pharma (EPIX) Short Interest Ratio & Short Volume

ESSA Pharma logo
$1.79 +0.02 (+1.13%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.80 +0.00 (+0.28%)
As of 04/17/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESSA Pharma Short Interest Data

ESSA Pharma (EPIX) has a short interest of 634,900 shares, representing 1.69% of the float (the number of shares available for trading by the public). This marks a -0.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.7, indicating that it would take 3.7 days of the average trading volume of 327,330 shares to cover all short positions.

Current Short Interest
634,900 shares
Previous Short Interest
639,100 shares
Change Vs. Previous Month
-0.66%
Dollar Volume Sold Short
$1.00 million
Short Interest Ratio
3.7 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
44,389,000 shares
Short Percent of Float
1.69%
Today's Trading Volume
177,602 shares
Average Trading Volume
327,330 shares
Today's Volume Vs. Average
54%
Short Selling ESSA Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ESSA Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EPIX Short Interest Over Time

EPIX Days to Cover Over Time

EPIX Percentage of Float Shorted Over Time

ESSA Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2025634,900 shares $1.00 million -0.7%1.7%3.7 $1.58
3/15/2025639,100 shares $1.04 million -0.6%1.7%2.6 $1.62
2/28/2025643,100 shares $1.08 million -5.2%1.7%2.3 $1.68
2/15/2025678,200 shares $1.17 million +6.3%1.8%2.2 $1.73
1/31/2025638,200 shares $1.10 million -4.6%N/A1.7 $1.72
1/15/2025668,900 shares $1.18 million -25.8%N/A0.7 $1.76
12/31/2024901,200 shares $1.61 million -5.3%N/A0.9 $1.79
12/15/2024951,500 shares $1.56 million +37.6%N/A1.1 $1.64
11/30/2024691,500 shares $1.24 million -4.8%N/A0.8 $1.79
11/15/2024726,500 shares $1.25 million -36.8%N/A0.9 $1.72
10/31/20241,150,000 shares $5.98 million No ChangeN/A1.5 $5.20
10/15/20241,150,000 shares $6.84 million +2.7%N/A19.5 $5.95
9/30/20241,120,000 shares $6.79 million +4.7%N/A19.8 $6.06
9/15/20241,070,000 shares $7.33 million +3.9%N/A19.1 $6.85
8/31/20241,030,000 shares $5.76 million No ChangeN/A18.9 $5.59
8/15/20241,030,000 shares $4.91 million +3.0%N/A23.6 $4.77
7/31/20241,000,000 shares $5.35 million -1.0%N/A20.4 $5.35
7/15/20241,010,000 shares $5.67 million No ChangeN/A18.7 $5.61
6/30/20241,010,000 shares $5.31 million +14.4%N/A18.4 $5.26
6/15/2024883,100 shares $4.74 million +4.7%N/A14.2 $5.37
5/31/2024843,700 shares $5.69 million -7.6%N/A14.4 $6.75
5/15/2024913,100 shares $5.66 million -1.5%N/A13.9 $6.20
4/30/2024926,500 shares $5.96 million +20.4%N/A8.7 $6.43
4/15/2024769,300 shares $5.62 million -4.2%N/A5.8 $7.30
3/31/2024802,800 shares $6.82 million -13.6%N/A5.2 $8.49
3/15/2024928,600 shares $8.36 million -5.2%4.6%6.1 $9.00
2/29/2024979,400 shares $9.30 million -13.3%4.8%6.3 $9.50
2/15/20241,130,000 shares $11.25 million -19.9%5.6%7.4 $9.96
1/31/20241,410,000 shares $11.69 million +5.2%7.1%9.5 $8.29
1/15/20241,340,000 shares $13.32 million No Change6.7%7.8 $9.94
12/31/20231,340,000 shares $8.84 million -1.5%6.7%6.9 $6.60
12/15/20231,360,000 shares $8.47 million -2.9%6.8%7.1 $6.23
11/30/20231,400,000 shares $7.45 million +1.5%7.0%7.7 $5.32
11/15/20231,380,000 shares $7.25 million +1.5%6.9%7.8 $5.25
10/31/20231,360,000 shares $6.32 million +3,959.7%6.8%8.3 $4.65
10/15/202333,500 shares $91,790.00 -32.5%0.2%0.3 $2.74
9/30/202349,600 shares $153,264.00 +73.4%0.3%1.7 $3.09
9/15/202328,600 shares $75,790.00 -4.7%0.1%0.9 $2.65
8/31/202330,000 shares $90,000.00 -42.2%0.2%0.9 $3.00
8/15/202351,900 shares $159,852.00 +8.1%0.3%1.4 $3.08
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
7/31/202348,000 shares $144,960.00 -29.1%0.2%1.3 $3.02
7/15/202367,700 shares $192,945.00 -27.9%0.4%1.7 $2.85
6/30/202393,900 shares $253,530.00 -21.6%0.5%1.9 $2.70
6/15/2023119,700 shares $389,025.00 -18.5%0.6%2.2 $3.25
5/31/2023146,900 shares $440,700.00 -14.1%0.8%2.2 $3.00
5/15/2023171,000 shares $499,320.00 -11.2%0.9%2.3 $2.92
4/30/2023192,600 shares $529,650.00 -33.8%1.0%1.7 $2.75
4/15/2023290,900 shares $805,793.00 +2.8%1.6%1.9 $2.77
3/31/2023282,900 shares $840,213.00 -1.4%1.5%1.4 $2.97
3/15/2023287,000 shares $826,560.00 +21.2%1.5%1.3 $2.88
2/28/2023236,800 shares $796,832.00 +17.0%1.3%1 $3.37
2/15/2023202,400 shares $718,520.00 -26.6%1.1%0.7 $3.55
1/31/2023275,800 shares $783,272.00 -20.6%1.5%0.9 $2.84
1/15/2023347,500 shares $966,050.00 -1.6%1.9%0.1 $2.78
12/30/2022353,000 shares $889,560.00 -18.1%1.9%0.1 $2.52
12/15/2022431,100 shares $1.22 million -20.9%2.3%0.1 $2.84
11/30/2022545,000 shares $2.01 million -11.9%2.9%0.2 $3.69
11/15/2022618,300 shares $2.46 million -69.4%3.3%0.2 $3.98
10/31/20222,020,000 shares $7.27 million +472.9%11.6%0.6 $3.60
10/15/2022352,600 shares $691,096.00 -5.7%2.0%2.1 $1.96
9/30/2022373,800 shares $680,316.00 +5.4%2.2%1.5 $1.82
9/15/2022354,500 shares $794,080.00 -5.5%2.0%0.9 $2.24
8/31/2022375,000 shares $967,500.00 +28.1%2.2%1 $2.58
8/15/2022292,800 shares $878,400.00 -8.7%1.7%0.7 $3.00
7/31/2022320,800 shares $907,864.00 -3.2%1.9%0.8 $2.83
7/15/2022331,400 shares $1.05 million -85.2%1.9%0.8 $3.17
6/30/20222,240,000 shares $7.06 million -4.7%12.9%7.4 $3.15
6/15/20222,350,000 shares $10.55 million -7.1%13.5%10.2 $4.49
5/31/20222,530,000 shares $12.78 million +1.2%14.6%9.5 $5.05
5/15/20222,500,000 shares $14.78 million +11.6%14.4%10 $5.91
4/30/20222,240,000 shares $12.70 million +4.7%13.1%9.1 $5.67
4/15/20222,140,000 shares $16.16 million +13.2%12.5%8.7 $7.55
3/31/20221,890,000 shares $11.68 million +81.7%11.0%6.9 $6.18
3/15/20221,040,000 shares $6.56 million +43.6%6.1%4.8 $6.31
2/28/2022724,100 shares $5.92 million +9.8%4.2%4 $8.17
2/15/2022659,800 shares $6.44 million +21.8%3.9%3.2 $9.76
1/31/2022541,800 shares $5.04 million -17.7%3.2%2.1 $9.31
1/15/2022658,100 shares $6.13 million -8.6%3.8%2.5 $9.32
12/31/2021720,200 shares $10.23 million -10.1%4.3%3.1 $14.20
12/15/2021800,900 shares $10.36 million -23.0%4.8%3.2 $12.94
11/30/20211,040,000 shares $13.89 million +11.0%6.2%4 $13.36
11/15/2021937,100 shares $12.17 million -25.0%5.6%3.2 $12.99
10/29/20211,250,000 shares $11.38 million +8.7%7.6%2.5 $9.10
10/15/20211,150,000 shares $9.33 million +2.7%7.0%2.1 $8.11
9/30/20211,120,000 shares $8.96 million -8.2%6.8%1.9 $8.00
9/15/20211,220,000 shares $10.57 million +3.4%7.4%2.1 $8.66
8/31/20211,180,000 shares $11.19 million -28.9%7.2%2.1 $9.48
8/13/20211,660,000 shares $19.79 million +55.1%10.3%3.2 $11.92
7/30/20211,070,000 shares $23.94 million +10.0%6.7%3.5 $22.37
7/15/2021972,500 shares $24.25 million +11.5%6.1%4.1 $24.94
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
6/30/2021872,200 shares $24.92 million +7.6%5.5%3.9 $28.57
6/15/2021810,600 shares $21.76 million +417.6%5.1%3.6 $26.84
5/28/2021156,600 shares $4.95 million -7.8%1.0%0.6 $31.62
5/14/2021169,900 shares $4.61 million -37.3%1.1%0.7 $27.15
4/30/2021271,000 shares $8.35 million +47.0%1.8%0.8 $30.83
4/15/2021184,300 shares $4.91 million +13.5%1.2%0.5 $26.64
3/31/2021162,400 shares $4.98 million +9.1%1.1%0.4 $30.67
3/15/2021148,900 shares $4.78 million +139.4%1.0%0.4 $32.08
2/26/202162,200 shares $1.58 million -0.8%0.4%0.2 $25.43
2/12/202162,700 shares $1.80 million +37.5%0.4%0.2 $28.65
1/29/202145,600 shares $777,480.00 +8.3%0.3%0.2 $17.05
1/15/202142,100 shares $666,443.00 -38.4%0.3%0.2 $15.83
12/31/202068,300 shares $808,672.00 +349.3%0.5%0.5 $11.84
12/15/202015,200 shares $107,464.00 +149.2%0.1%0.1 $7.07
11/30/20206,100 shares $39,955.00 -47.0%0.0%0.1 $6.55
11/15/202011,500 shares $74,405.00 -9.5%0.1%0.1 $6.47
10/30/202012,700 shares $69,469.00 +84.1%0.1%0.1 $5.47
10/15/20206,900 shares $46,092.00 -64.1%0.1%0.1 $6.68
9/30/202019,200 shares $132,480.00 +62.7%0.1%0.1 $6.90
9/15/202011,800 shares $91,922.00 -51.4%0.1%0.1 $7.79
8/31/202024,300 shares $170,829.00 -20.9%0.2%0.2 $7.03
8/14/202030,700 shares $210,295.00 -38.8%0.2%0.3 $6.85
7/31/202050,200 shares $350,898.00 +63.5%0.3%0.6 $6.99
7/15/202030,700 shares $184,507.00 -6.1%0.2%0.7 $6.01
6/30/202032,700 shares $196,854.00 +23.9%0.2%1 $6.02
6/15/202026,400 shares $133,320.00 -1.9%0.2%1 $5.05
5/29/202026,900 shares $140,418.00 -3.6%0.2%1.1 $5.22
5/15/202027,900 shares $128,340.00 +4.1%0.2%1 $4.60
4/30/202026,800 shares $119,260.00 -6.0%0.2%0.8 $4.45

EPIX Short Interest - Frequently Asked Questions

What is ESSA Pharma's current short interest?

Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 634,900 shares of EPIX short. 1.69% of ESSA Pharma's shares are currently sold short. Learn More on ESSA Pharma's current short interest.

What is a good short interest ratio for ESSA Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EPIX shares currently have a short interest ratio of 4.0. Learn More on ESSA Pharma's short interest ratio.

Which institutional investors are shorting ESSA Pharma?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ESSA Pharma: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for ESSA Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.69% of ESSA Pharma's floating shares are currently sold short.

Is ESSA Pharma's short interest increasing or decreasing?

ESSA Pharma saw a decrease in short interest in March. As of March 31st, there was short interest totaling 634,900 shares, a decrease of 0.7% from the previous total of 639,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ESSA Pharma's short interest compare to its competitors?

1.69% of ESSA Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ESSA Pharma: Cryoport, Inc. (5.08%), COMPASS Pathways plc (7.98%), Olema Pharmaceuticals, Inc. (14.07%), Arcturus Therapeutics Holdings Inc. (19.08%), Aura Biosciences, Inc. (3.18%), Atai Life Sciences (8.64%), Monte Rosa Therapeutics, Inc. (11.76%), Atyr PHARMA INC (9.67%), Taysha Gene Therapies, Inc. (10.85%), 2seventy bio, Inc. (5.79%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short ESSA Pharma stock?

Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. EPIX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ESSA Pharma?

A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further.

How often is ESSA Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:EPIX) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners